Stock image Insulin Like
Cropped View Of Social Worker Showing Thumb Up Near Glucometer And Senior Diabetic Woman
Image, 8.86MB, 7360 × 4912 jpg
Papers With Hormones List And Tablet With Words Insulin-like Growth Factor-1 (IGF-1).
Image, 5.54MB, 5500 × 3667 jpg
Structure Of Insulin-like Growth Factor 1 (IGF-1), 3D Cartoon Model Of The Tertiary Structure With The Elements Of The Secondary Structure Colored, White Background
Image, 1.25MB, 6000 × 4000 jpg
Structure Of Human Hormone Insulin-like Peptide-5 Heterodimer, 3D Cartoon And Gaussian Surface Models, White Background
Image, 2.56MB, 8000 × 4000 jpg
3D Rendering Of Glucagon-like Peptide 1 (GLP1, 7-36) Molecule, A Potent Antihyperglycemic Hormone. A Neuropeptide And An Incretin, Treatment Of Diabetes, Molecular Surface. 3d Illustration
Image, 2.9MB, 8000 × 4500 jpg
Functions Of Glucagon-like Peptide-1. Weight Loss. GLP-1. Treatment Of Diabetes. Physiological Properties Of Peptide Hormone. Humans Internal Organs. Vector Diagram
Vector, 9.15MB, 4444 × 4444 eps
Structure Of Human Hormone Insulin-like Peptide-3 Heterodimer, 3D Cartoon And Gaussian Surface Models, White Background
Image, 3.16MB, 10000 × 4000 jpg
Glucagon-like Peptide-1. Weight Loss. Physiological Functions Of GLP-1: Promote Satiety And Insulin Release, Inhibit Glucagon Secretion, Appetite, Gastric Motility And Emptying. Target Organs For Peptide Hormone. Treatment Of Diabetes. Vector Diagram
Vector, 2.25MB, 4444 × 4443 eps
GLP-1. Glucagon-like Peptide-1 For Appetite Regulation, Weight Loss And Treatment Of Diabetes. Peptide Hormone Functions And Effects On Human Internal Organs. Vector Diagram
Vector, 10.53MB, 4444 × 4444 eps
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.52MB, 4032 × 3024 jpg
Growth Hormone. Somatotropin. Close-up Of A Hypothalamus And Pituitary Gland. Posterior And Anterior Pituitary. An Excess Of GH Cause Acromegaly Excessive Growth Of The Bones. GH Deficiency Lead To Dwarfism Or Growth Retardation. Vector Diagram
Vector, 1.88MB, 4444 × 4444 eps
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.39MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.37MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.39MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.37MB, 3024 × 4032 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.55MB, 3024 × 4032 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.42MB, 3024 × 4032 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.49MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.35MB, 4032 × 3024 jpg
Doctor Holding A Test Blood Sample Tube With IGF-1 Test On The Background Of Medical Test Tubes With Analyzes.
Image, 8.91MB, 6000 × 4000 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.41MB, 3024 × 4032 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.54MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.25MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.6MB, 4032 × 3024 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.53MB, 3024 × 4032 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.52MB, 4032 × 3024 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.3MB, 3024 × 4032 jpg
Doctor Holding A Test Blood Sample Tube With IGF-1 Test On The Background Of Medical Test Tubes With Analyzes.
Image, 4.51MB, 6000 × 2213 jpg
Glucagon-like Peptide-1. GLP-1 From Blood Vessel To Pancreas, Brain And Stomach. Relationship Between Satiety, Appetite Hormones, Insulin, Glucagon, Gastric Motility And Emptying. Vector Isometric Flat Illustration.
Vector, 2.58MB, 11801 × 8257 eps
Glucagon-like Peptide 1 (GLP1, 7-36) Molecule, A Potent Antihyperglycemic Hormone. A Neuropeptide And An Incretin, Chemical Structure. Treatment Of Diabetes, Molecular Surface, 3d Render
Image, 7.01MB, 8000 × 4500 jpg
Growth Hormone. Somatotropin. Hypothalamic-Pituitary-Somatotropic HPS Axis. GH Stimulates Liver Of IGF-1 Release. Close-up Of A Hypothalamus And Pituitary Gland. Posterior And Anterior Pituitary. Vector Diagram
Vector, 13.16MB, 4444 × 4444 eps
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.63MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.19MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.41MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.58MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.41MB, 3024 × 4032 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.44MB, 4032 × 3024 jpg
Glucagon-like Peptide 1 (GLP1, 7-36) Molecule, A Potent Antihyperglycemic Hormone. A Neuropeptide And An Incretin, Chemical Structure. Treatment Of Diabetes, Molecular Surface, 3d Render
Image, 7.8MB, 8000 × 4500 jpg
Glucagon-like Peptide 1 (GLP1, 7-36) Molecule, A Potent Antihyperglycemic Hormone. A Neuropeptide And An Incretin, Chemical Structure. Treatment Of Diabetes, Molecular Surface, 3d Render
Image, 7.7MB, 8000 × 4500 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.21MB, 3024 × 4032 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.32MB, 3024 × 4032 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.56MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.69MB, 4032 × 3024 jpg
Prague,Czech Republic-June 17 2024 Box Of Medication With Semaglutide Active Substance By Novo Nordisk,used For Treatment Of Diabetes,Type 2 Diabetes
Image, 2.28MB, 4032 × 3024 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.53MB, 4032 × 3024 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.43MB, 3024 × 4032 jpg
Prague,Czech Republic-June 27 2024: VICTOZA Medication With Liraglutide Active Substance By Novo Nordisk, Used For Treatment Of Diabetes Mellitus Type 2, Weight Management, Hyperglycemia,injection
Image, 2.33MB, 4032 × 3024 jpg
Page 1 >> Next